UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 165

Sortiert nach

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome

World journal of gastroenterology : WJG, 2018-10, Vol.24 (37), p.4217-4223

2018

Link zum Volltext

Verfügbarkeit prüfen

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

The New England journal of medicine, 2017-06, Vol.376 (22), p.2122-2133

2017

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic changes in patients with multiple sclerosis

Nature reviews. Neurology, 2013-01, Vol.9 (1), p.35

2013

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity

Multiple sclerosis, 2020-10, Vol.26 (11), p.1340-1350

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinically Isolated Syndrome and Early Relapsing Multiple Sclerosis

Continuum (Minneapolis, Minn.), 2019-06, Vol.25 (3), p.670

Metz, Luanne M

2019

Link zum Volltext

Verfügbarkeit prüfen

An enrichment strategy for clinical trials in SPMS

Multiple sclerosis, 2021-10, Vol.27 (12), p.1884-1893

2021

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Annals of neurology, 2005-12, Vol.58 (6), p.840-846

2005

Link zum Volltext

Verfügbarkeit prüfen

Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent

Journal of neurology, 2020-09, Vol.267 (9), p.2619-2624

2020

Link zum Volltext

Verfügbarkeit prüfen

1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis

PloS one, 2015-12, Vol.10 (12), p.e0144084-e0144084

2015

Link zum Volltext

Verfügbarkeit prüfen

Hydroxychloroquine for Primary Progressive Multiple Sclerosis

Annals of neurology, 2021-12, Vol.90 (6), p.940-948

2021

Link zum Volltext

Verfügbarkeit prüfen

Multiple Sclerosis Clinic Utilization is Associated with Fewer Emergency Department Visits

Canadian journal of neurological sciences, 2022-05, Vol.49 (3), p.393-397

2022

Link zum Volltext

Verfügbarkeit prüfen

Effective treatment of progressive MS remains elusive

The Lancet (British edition), 2018-03, Vol.391 (10127), p.1239-1240

2018

Link zum Volltext

Verfügbarkeit prüfen

Advanced diffusion MRI and image texture analysis detect widespread brain structural differences between relapsing-remitting and secondary progressive multiple sclerosis

Frontiers in human neuroscience, 2022-08, Vol.16, p.944908-944908

2022

Link zum Volltext

Verfügbarkeit prüfen

Advanced Analysis of Diffusion Tensor Imaging Along With Machine Learning Provides New Sensitive Measures of Tissue Pathology and Intra-Lesion Activity in Multiple Sclerosis

Frontiers in neuroscience, 2021-05, Vol.15, p.634063-634063

2021

Link zum Volltext

Verfügbarkeit prüfen

Reduction of microglial activity in a model of multiple sclerosis by dipyridamole

Journal of neuroinflammation, 2013-07, Vol.10 (1), p.89-89, Article 855

2013

Link zum Volltext

Verfügbarkeit prüfen

Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic

Nature communications, 2017-12, Vol.8 (1), p.1990-15, Article 1990

2017

Link zum Volltext

Verfügbarkeit prüfen

Depression in multiple sclerosis: A long-term longitudinal study

Multiple sclerosis, 2015-01, Vol.21 (1), p.76-82

2015

Link zum Volltext

Verfügbarkeit prüfen

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

Journal of neuroinflammation, 2015-03, Vol.12 (1), p.55-55, Article 55

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study

PloS one, 2015-04, Vol.10 (4), p.e0123824-e0123824

2015

Link zum Volltext

Verfügbarkeit prüfen

Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?

Multiple sclerosis, 2018-10, Vol.24 (12), p.1543-1556

2018

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis-related fatigue: the role of impaired corticospinal responses and heightened exercise fatigability

Journal of neurophysiology, 2020-10, Vol.124 (4), p.1131-1143

2020

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoids and bladder symptoms in multiple sclerosis

Multiple sclerosis and related disorders, 2021-09, Vol.54, p.103105-103105, Article 103105

2021

Link zum Volltext

Verfügbarkeit prüfen

The promise of minocycline in neurology

Lancet neurology, 2004-12, Vol.3 (12), p.744-751

2004

Link zum Volltext

Verfügbarkeit prüfen

Distinct characteristics and severity of brain magnetic resonance imaging lesions in women and men with multiple sclerosis assessed using verified texture analysis measures

Frontiers in neurology, 2023-08, Vol.14, p.1213377-1213377

2023

Link zum Volltext

Verfügbarkeit prüfen

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis

Trends in molecular medicine, 2013-01, Vol.19 (1), p.23-30

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

Englisch
(165)
Japanisch
(10)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

Epigenetic changes in patients with multiple sclerosis

Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity

Clinically Isolated Syndrome and Early Relapsing Multiple Sclerosis

An enrichment strategy for clinical trials in SPMS

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent

1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis

Hydroxychloroquine for Primary Progressive Multiple Sclerosis

Multiple Sclerosis Clinic Utilization is Associated with Fewer Emergency Department Visits

Effective treatment of progressive MS remains elusive

Advanced diffusion MRI and image texture analysis detect widespread brain structural differences between relapsing-remitting and secondary progressive multiple sclerosis

Advanced Analysis of Diffusion Tensor Imaging Along With Machine Learning Provides New Sensitive Measures of Tissue Pathology and Intra-Lesion Activity in Multiple Sclerosis

Reduction of microglial activity in a model of multiple sclerosis by dipyridamole

Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic

Depression in multiple sclerosis: A long-term longitudinal study

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study

Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?

Multiple sclerosis-related fatigue: the role of impaired corticospinal responses and heightened exercise fatigability

Cannabinoids and bladder symptoms in multiple sclerosis

The promise of minocycline in neurology

Distinct characteristics and severity of brain magnetic resonance imaging lesions in women and men with multiple sclerosis assessed using verified texture analysis measures

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis

Suchergebnisse filtern